Schwartz Investment Counsel Inc. Trims Stock Position in Chemed Corporation $CHE

Schwartz Investment Counsel Inc. trimmed its stake in Chemed Corporation (NYSE:CHE) by 73.7% during the first quarter, HoldingsChannel reports. The institutional investor owned 17,020 shares of the company’s stock after selling 47,714 shares during the period. Schwartz Investment Counsel Inc.’s holdings in Chemed were worth $6,429,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Geneos Wealth Management Inc. grew its stake in Chemed by 330.4% during the 1st quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock worth $61,000 after buying an additional 76 shares during the last quarter. Arrowstreet Capital Limited Partnership lifted its stake in Chemed by 67.0% in the second quarter. Arrowstreet Capital Limited Partnership now owns 11,365 shares of the company’s stock valued at $5,534,000 after buying an additional 4,560 shares during the last quarter. Marshall Wace LLP acquired a new stake in shares of Chemed in the second quarter valued at approximately $579,000. Brown Advisory Inc. boosted its holdings in shares of Chemed by 36.9% in the second quarter. Brown Advisory Inc. now owns 549 shares of the company’s stock valued at $267,000 after acquiring an additional 148 shares during the period. Finally, Cerity Partners LLC grew its position in shares of Chemed by 237.7% during the second quarter. Cerity Partners LLC now owns 4,451 shares of the company’s stock worth $2,165,000 after acquiring an additional 3,133 shares during the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction that occurred on Friday, May 1st. The stock was sold at an average price of $421.13, for a total value of $842,260.00. Following the completion of the sale, the chief executive officer directly owned 90,219 shares of the company’s stock, valued at $37,993,927.47. This trade represents a 2.17% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Andrea R. Lindell sold 1,347 shares of Chemed stock in a transaction that occurred on Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total value of $602,553.51. Following the completion of the sale, the director owned 4,578 shares in the company, valued at approximately $2,047,876.74. This trade represents a 22.73% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 3.33% of the stock is currently owned by insiders.

Chemed Price Performance

Chemed stock opened at $493.04 on Tuesday. The company has a debt-to-equity ratio of 0.11, a current ratio of 0.85 and a quick ratio of 0.83. The business has a 50 day simple moving average of $444.52 and a 200-day simple moving average of $429.08. Chemed Corporation has a 12 month low of $365.20 and a 12 month high of $496.15. The stock has a market capitalization of $6.54 billion, a PE ratio of 26.87, a price-to-earnings-growth ratio of 1.80 and a beta of 0.52.

Chemed (NYSE:CHE) last announced its quarterly earnings data on Thursday, April 23rd. The company reported $5.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.30 by $0.35. The company had revenue of $657.51 million for the quarter, compared to analysts’ expectations of $659.22 million. Chemed had a net margin of 10.23% and a return on equity of 27.18%. Chemed’s revenue was up 1.6% compared to the same quarter last year. During the same period in the previous year, the company posted $5.63 EPS. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. Equities analysts predict that Chemed Corporation will post 22.67 earnings per share for the current year.

Chemed Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 16th. Investors of record on Thursday, May 28th were given a $0.60 dividend. The ex-dividend date was Thursday, May 28th. This represents a $2.40 dividend on an annualized basis and a yield of 0.5%. Chemed’s dividend payout ratio (DPR) is presently 13.08%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the stock. Bank of America lifted their target price on shares of Chemed from $450.00 to $510.00 and gave the company a “neutral” rating in a report on Thursday, July 9th. Weiss Ratings raised shares of Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, April 29th. Royal Bank Of Canada lifted their price objective on shares of Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a research note on Monday, April 27th. Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Finally, Wall Street Zen downgraded shares of Chemed from a “buy” rating to a “hold” rating in a research note on Monday, June 8th. One research analyst has rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $480.25.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.